100.86 USD
-3.03 (-2.92%)
100.86 USD
0 (0%)
IRMD gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. IRMD gets an excellent profitability rating and is at the same time showing great financial health properties. IRMD has a decent growth rate and is not valued too expensively. With these ratings, IRMD could be worth investigating further for quality investing!.
1. Profitability
1.1 Basic Checks
- IRMD had positive earnings in the past year.
- IRMD had a positive operating cash flow in the past year.
- In the past 5 years IRMD has always been profitable.
- In the past 5 years IRMD always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 18.47%, IRMD belongs to the top of the industry, outperforming 98.92% of the companies in the same industry.
- IRMD has a Return On Equity of 21.54%. This is amongst the best in the industry. IRMD outperforms 94.62% of its industry peers.
- IRMD has a better Return On Invested Capital (19.30%) than 97.31% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for IRMD is significantly above the industry average of 8.84%.
- The last Return On Invested Capital (19.30%) for IRMD is above the 3 year average (18.78%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.47% | ||
| ROE | 21.54% | ||
| ROIC | 19.3% |
ROA(3y)17.74%
ROA(5y)13.28%
ROE(3y)21.21%
ROE(5y)15.76%
ROIC(3y)18.78%
ROIC(5y)N/A
1.3 Margins
- IRMD has a Profit Margin of 26.31%. This is amongst the best in the industry. IRMD outperforms 95.70% of its industry peers.
- In the last couple of years the Profit Margin of IRMD has remained more or less at the same level.
- Looking at the Operating Margin, with a value of 30.87%, IRMD belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
- In the last couple of years the Operating Margin of IRMD has grown nicely.
- IRMD's Gross Margin of 77.07% is amongst the best of the industry. IRMD outperforms 89.25% of its industry peers.
- IRMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 30.87% | ||
| PM (TTM) | 26.31% | ||
| GM | 77.07% |
OM growth 3Y8.49%
OM growth 5Y5.96%
PM growth 3Y5.58%
PM growth 5Y0.99%
GM growth 3Y0.12%
GM growth 5Y-0.04%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IRMD is creating value.
- Compared to 1 year ago, IRMD has more shares outstanding
- IRMD has more shares outstanding than it did 5 years ago.
- There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- IRMD has an Altman-Z score of 50.00. This indicates that IRMD is financially healthy and has little risk of bankruptcy at the moment.
- IRMD has a better Altman-Z score (50.00) than 98.92% of its industry peers.
- There is no outstanding debt for IRMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 50 |
ROIC/WACC1.93
WACC10%
2.3 Liquidity
- IRMD has a Current Ratio of 6.64. This indicates that IRMD is financially healthy and has no problem in meeting its short term obligations.
- IRMD's Current ratio of 6.64 is amongst the best of the industry. IRMD outperforms 84.95% of its industry peers.
- A Quick Ratio of 5.72 indicates that IRMD has no problem at all paying its short term obligations.
- IRMD's Quick ratio of 5.72 is amongst the best of the industry. IRMD outperforms 85.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.64 | ||
| Quick Ratio | 5.72 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 13.75% over the past year.
- The Earnings Per Share has been growing by 13.92% on average over the past years. This is quite good.
- Looking at the last year, IRMD shows a quite strong growth in Revenue. The Revenue has grown by 12.91% in the last year.
- The Revenue has been growing by 13.71% on average over the past years. This is quite good.
EPS 1Y (TTM)13.75%
EPS 3Y25.74%
EPS 5Y13.92%
EPS Q2Q%9.3%
Revenue 1Y (TTM)12.91%
Revenue growth 3Y20.55%
Revenue growth 5Y13.71%
Sales Q2Q%15.69%
3.2 Future
- IRMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.26% yearly.
- The Revenue is expected to grow by 8.97% on average over the next years. This is quite good.
EPS Next Y15.29%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
EPS Next 5YN/A
Revenue Next Year13.26%
Revenue Next 2Y11.69%
Revenue Next 3Y8.97%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 55.42, which means the current valuation is very expensive for IRMD.
- IRMD's Price/Earnings ratio is a bit cheaper when compared to the industry. IRMD is cheaper than 68.28% of the companies in the same industry.
- The average S&P500 Price/Earnings ratio is at 27.21. IRMD is valued rather expensively when compared to this.
- With a Price/Forward Earnings ratio of 46.64, IRMD can be considered very expensive at the moment.
- 69.35% of the companies in the same industry are more expensive than IRMD, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 24.26. IRMD is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.42 | ||
| Fwd PE | 46.64 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IRMD indicates a somewhat cheap valuation: IRMD is cheaper than 66.67% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, IRMD is valued a bit cheaper than 70.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 91.97 | ||
| EV/EBITDA | 47.47 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRMD does not grow enough to justify the current Price/Earnings ratio.
- IRMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)3.62
PEG (5Y)3.98
EPS Next 2Y14.48%
EPS Next 3Y9.26%
5. Dividend
5.1 Amount
- IRMD has a yearly dividend return of 0.65%, which is pretty low.
- Compared to an average industry Dividend Yield of 0.20, IRMD pays a better dividend. On top of this IRMD pays more dividend than 91.40% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.81, IRMD's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.65% |
5.2 History
- IRMD has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 39.59% of the earnings are spent on dividend by IRMD. This is a low number and sustainable payout ratio.
DP39.59%
EPS Next 2Y14.48%
EPS Next 3Y9.26%
IRADIMED CORP / IRMD FAQ
Can you provide the ChartMill fundamental rating for IRADIMED CORP?
ChartMill assigns a fundamental rating of 7 / 10 to IRMD.
Can you provide the valuation status for IRADIMED CORP?
ChartMill assigns a valuation rating of 4 / 10 to IRADIMED CORP (IRMD). This can be considered as Fairly Valued.
Can you provide the profitability details for IRADIMED CORP?
IRADIMED CORP (IRMD) has a profitability rating of 9 / 10.
What are the PE and PB ratios of IRADIMED CORP (IRMD) stock?
The Price/Earnings (PE) ratio for IRADIMED CORP (IRMD) is 55.42 and the Price/Book (PB) ratio is 13.04.
Can you provide the financial health for IRMD stock?
The financial health rating of IRADIMED CORP (IRMD) is 9 / 10.